| Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|
| Cash and cash equivalents | 20 | 25 | 23 | 21 | - | 7 | 8 | 7 | 17 | 4 |
|---|
| Note receivable - LINICO | - | - | - | - | - | - | - | - | 1 | 0 |
|---|
| Accounts receivable | - | - | 1 | 1 | 0 | 0 | 0 | 0 | 0 | - |
|---|
| Inventory | - | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 |
|---|
| Prepaid expenses and other current assets | 146,987 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 |
|---|
| Total current assets | 32 | 27 | 26 | 23 | 28 | 8 | 12 | 23 | 18 | 5 |
|---|
| Property, plant and equipment, net | 9 | 41 | 46 | 46 | 38 | 25 | 2 | 7 | 10 | 16 |
|---|
| Intellectual property, net | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
|---|
| Other assets | 2 | 2 | 2 | 2 | 3 | 1 | 1 | 0 | 5 | 5 |
|---|
| Total non-current assets | 15 | 44 | 49 | 49 | 42 | 27 | 21 | 10 | 15 | 22 |
|---|
| Total assets | 47 | 72 | 74 | 71 | 69 | 35 | 33 | 34 | 34 | 26 |
|---|
| Accounts payable | 3 | 2 | 1 | 2 | 5 | 2 | 1 | 1 | 2 | 1 |
|---|
| Accrued Expenses | 80,518 | 2 | 2 | 5 | 4 | 1 | 3 | 2 | 2 | 3 |
|---|
| Operating and Finance Lease Liability, Current | - | - | - | - | - | 1 | 0 | 0 | 0 | 0 |
|---|
| Related Party | - | - | - | - | - | - | - | - | - | 0 |
|---|
| Nonrelated Party | - | - | - | - | - | - | - | - | - | 3 |
|---|
| Notes payable, current portion | 44,966 | 0 | 0 | 0 | 0 | 0 | - | 6 | 0 | 4 |
|---|
| Total current liabilities | 3 | 4 | 4 | 12 | 10 | 3 | 4 | 12 | 5 | 8 |
|---|
| Operating and Finance Lease, Liability, Noncurrent | - | - | - | - | - | 0 | 0 | 0 | - | 0 |
|---|
| Notes payable, non-current portion | 9 | 9 | 9 | 9 | 8 | 0 | - | - | - | - |
|---|
| Warrant liability | - | - | - | - | - | - | - | - | - | 1 |
|---|
| Total liabilities | 14 | 15 | 15 | 21 | 20 | 4 | 6 | 13 | 8 | 10 |
|---|
| Common stock; $0.001 par value; 300,000,000 shares authorized; 7,760,255 and 7,730,836, shares issued and outstanding as of December 31, 2024, respectively and 5,415,433 and 5,394,005 shares issued and outstanding as of December 31, 2023 | 14,137 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|---|
| Additional paid-in capital | 48 | 85 | 114 | 145 | 189 | 197 | 211 | 220 | 250 | 264 |
|---|
| Accumulated deficit | -14,705,388 | -28 | -55 | -95 | -140 | -166 | -184 | -199 | -223 | -248 |
|---|
| Treasury stock, at cost; common shares: 29,419 and 21,428 as of December 31, 2024 and December 31, 2023, respectively | - | - | - | - | - | - | - | - | 1 | 0 |
|---|
| Total stockholders’ equity | 34 | 57 | 59 | 50 | 50 | 31 | 28 | 21 | 26 | 16 |
|---|
| Total liabilities and stockholders’ equity | 47 | 72 | 74 | 71 | 69 | 35 | 33 | 34 | 34 | 26 |
|---|